Text Size

Representation of the Body for Patients With Cancer (CORCAN)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT01560533
First received: December 12, 2011
Last updated: May 15, 2013
Last verified: June 2011
History of Changes

December 12, 2011
May 15, 2013
November 2011
January 2013   (final data collection date for primary outcome measure)
Body representations [ Time Frame: 3 months ] [ Designated as safety issue: No ]

Comprehensive knowledge concerning the way the patients are living cancer event, treatment, changes in their body representations and conceptions of their lives.

This qualitative study do not include outcome measures. Its purpose is restricted to the meanings
Same as current
Complete list of historical versions of study NCT01560533 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Representation of the Body for Patients With Cancer
Representation of the Body and Treatment of Peritoneal Cancer by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - A Collaborative Approach Between Professionals of Health / Patients / Researchers

The project aims to understand better how patients live the event of cancer and live its consequences on their bodily representations. In the study, the dynamic of the body image is not restricted to appearance but include sensations and visions of the inner body, what explains the choice of peritoneal cancer, and the treatment by cytoreductive surgery and HIPEC.

The three objectives of the study are:

  • identifying the impact of the representations of the treated body on the psychological strategies to cope with the disease, the bodily changes and the prospects of life;
  • making explicit the positive or negative impacts of these representations on the relationship between patients and health professionals (easing factors, misunderstandings, negotiations, etc.);
  • associating the health professionals with the study in its course and evaluation in order to elaborate a methodological collaborative approach between patients, health professionals and researchers in social sciences.
Not Provided
Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Basic Science
Peritoneal Carcinomatosis
Behavioral: Interviews
Interviews will be done with patients
  • Treated by HIPEC
    Patients treated by HIPEC for peritoneal cancer
    Intervention: Behavioral: Interviews
  • Standard chemiotherapy
    Patients treated by standard chemiotherapy for peritoneal cancer
    Intervention: Behavioral: Interviews
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
21
January 2013
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients eligible to treatment of cancer by cytoreductive surgery and HIPEC
  • Primary (pseudomyxoma, mesothelioma) and secondary (colorectal, gastric, ovarian) peritoneal cancer
  • Free consent
  • Male or Female
  • Age > 18 years
  • Affiliate to social security

Exclusion Criteria:

  • Age < 18 years, no french speaking
  • Cerebrals metastasis
  • Psychiatrics diseases
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01560533
2010.640
No
Hospices Civils de Lyon
Hospices Civils de Lyon
Not Provided
Principal Investigator: Olivier GLEHEN, Pr Hospices Civiles de Lyon
Hospices Civils de Lyon
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP